-
Taxonomy & unit
-
us-gaap: USD
-
Description
-
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
-
Summary
-
KalVista Pharmaceuticals, Inc. quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from 2013 to 2023.
- KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the quarter ending April 30, 2024 was -$44.6M, a 69.7% decline year-over-year.
- KalVista Pharmaceuticals, Inc. Net Income (Loss) Attributable to Parent for the twelve months ending April 30, 2024 was -$127M, a 36.3% decline year-over-year.
- KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2023 was -$127M, a 36.3% decline from 2022.
- KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2022 was -$92.9M, a 12.8% decline from 2021.
- KalVista Pharmaceuticals, Inc. annual Net Income (Loss) Attributable to Parent for 2021 was -$82.3M, a 78.1% decline from 2020.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Annual (USD)
Net Income (Loss) Attributable to Parent, YoY Annual Growth (%)